Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

The lead time distribution when lifetime is subject to competing risks in cancer screening.

Wu D, Kafadar K, Rosner GL, Broemeling LD.

Int J Biostat. 2012;8(1). doi: 10.1515/1557-4679.1363.

PMID:
22611589
2.

Bayesian Estimation of Combined Accuracy for Tests with Verification Bias.

Broemeling LD.

Diagnostics (Basel). 2011 Dec 15;1(1):53-76. doi: 10.3390/diagnostics1010053.

3.

Bayesian Methods for Medical Test Accuracy.

Broemeling LD.

Diagnostics (Basel). 2011 May 5;1(1):1-35. doi: 10.3390/diagnostics1010001. Review.

4.

Bayesian inference for the lead time in periodic cancer screening.

Wu D, Rosner GL, Broemeling LD.

Biometrics. 2007 Sep;63(3):873-80.

5.

The reliability of measuring physical characteristics of spiculated masses on mammography.

Sampat MP, Whitman GJ, Stephens TW, Broemeling LD, Heger NA, Bovik AC, Markey MK.

Br J Radiol. 2006 Dec;79 Spec No 2:S134-40.

PMID:
17209119
6.

Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.

Marom EM, Munden RF, Truong MT, Gladish GW, Podoloff DA, Mawlawi O, Broemeling LD, Bruzzi JF, Macapinlac HA.

J Thorac Imaging. 2006 Aug;21(3):205-12.

PMID:
16915065
7.

Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model.

Gupta S, Kobayashi S, Phongkitkarun S, Broemeling LD, Kan Z.

Invest Radiol. 2006 Jun;41(6):516-21.

PMID:
16763470
8.

Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history.

Gladish GW, Choe DH, Marom EM, Sabloff BS, Broemeling LD, Munden RF.

Radiology. 2006 Jul;240(1):246-55. Epub 2006 May 9.

PMID:
16684921
9.

Tumor iNOS predicts poor survival for stage III melanoma patients.

Ekmekcioglu S, Ellerhorst JA, Prieto VG, Johnson MM, Broemeling LD, Grimm EA.

Int J Cancer. 2006 Aug 15;119(4):861-6.

10.

Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.

Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA.

J Thorac Cardiovasc Surg. 2005 Jun;129(6):1364-70.

11.

The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.

Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA.

J Nucl Med. 2005 Feb;46(2):248-52.

12.

Small (</=2-cm) subpleural pulmonary lesions: short- versus long-needle-path CT-guided Biopsy--comparison of diagnostic yields and complications.

Gupta S, Krishnamurthy S, Broemeling LD, Morello FA Jr, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME.

Radiology. 2005 Feb;234(2):631-7.

PMID:
15673500
13.

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.

Schechter NR, Wendt RE 3rd, Yang DJ, Azhdarinia A, Erwin WD, Stachowiak AM, Broemeling LD, Kim EE, Cox JD, Podoloff DA, Ang KK.

J Nucl Med. 2004 Oct;45(10):1683-7.

14.

NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.

Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y.

Oncogene. 2004 Nov 11;23(53):8681-7.

PMID:
15467753
15.

Biochemotherapy in patients with metastatic anorectal mucosal melanoma.

Kim KB, Sanguino AM, Hodges C, Papadopoulos NE, Eton O, Camacho LH, Broemeling LD, Johnson MM, Ballo MT, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Prieto VG, Bedikian AY.

Cancer. 2004 Apr 1;100(7):1478-83.

16.

Detection of small pancreatic tumors with multiphasic helical CT.

Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, Broemeling LD, Cleary KR, Charnsangavej C.

AJR Am J Roentgenol. 2004 Mar;182(3):619-23.

PMID:
14975959
17.

Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells.

Simeone AM, Li YJ, Broemeling LD, Johnson MM, Tuna M, Tari AM.

Cancer Res. 2004 Feb 15;64(4):1224-8.

18.
19.

Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.

Vadhan-Raj S, Patel S, Bueso-Ramos C, Folloder J, Papadopolous N, Burgess A, Broemeling LD, Broxmeyer HE, Benjamin RS.

J Clin Oncol. 2003 Aug 15;21(16):3158-67.

PMID:
12915607
20.

A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.

Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA, Tari AM.

Mol Cancer Ther. 2002 Oct;1(12):1009-17. Erratum in: Mol Cancer Ther. 2002 Dec;1(14):1366.

21.

Method for efficient fast spin echo Dixon imaging.

Ma J, Singh SK, Kumar AJ, Leeds NE, Broemeling LD.

Magn Reson Med. 2002 Dec;48(6):1021-7.

22.

CT-guided percutaneous fine-needle aspiration biopsy of small (< or =1-cm) pulmonary lesions.

Wallace MJ, Krishnamurthy S, Broemeling LD, Gupta S, Ahrar K, Morello FA Jr, Hicks ME.

Radiology. 2002 Dec;225(3):823-8.

PMID:
12461267
23.

Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.

Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B.

Lancet. 2002 Jun 22;359(9324):2145-52.

PMID:
12090979
24.

Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma.

Wang XS, Giralt SA, Mendoza TR, Engstrom MC, Johnson BA, Peterson N, Broemeling LD, Cleeland CS.

J Clin Oncol. 2002 Mar 1;20(5):1319-28.

PMID:
11870175
25.

Coronary artery calcium, coronary artery disease, and diabetes.

Mielke CH, Shields JP, Broemeling LD.

Diabetes Res Clin Pract. 2001 Jul;53(1):55-61.

PMID:
11378214
26.

Risk factors and coronary artery disease for asymptomatic women using electron beam computed tomography.

Mielke CH Jr, Shields JP, Broemeling LD.

J Cardiovasc Risk. 2001 Apr;8(2):81-6.

PMID:
11324374
27.

A bayesian analysis for spatial processes with application to disease mapping.

Bell BS, Broemeling LD.

Stat Med. 2000 Apr 15;19(7):957-74.

PMID:
10750062
28.

The case for aggressive resection.

Sekhar LN, Buchanan RI, Wright DC, Broemeling LD.

Clin Neurosurg. 1999;45:263-78. Review. No abstract available.

PMID:
10461527
29.

Comparison of fresh and cryopreserved human sperm attachment to bovine oviduct (uterine tube) epithelial cells in vitro.

Ellington JE, Broemeling LD, Broder SJ, Jones AE, Choker DA, Wright RW.

J Androl. 1999 Jul-Aug;20(4):492-9.

30.

Coronary risk assessment in women.

Broemeling LD, Mielke CH Jr.

Lancet. 1999 Jul 31;354(9176):426-7. No abstract available.

PMID:
10437899
31.

Confidence intervals for differences in correlated binary proportions.

Broemeling LD, Gregurich MA.

Stat Med. 1999 Jan 15;18(1):109. No abstract available.

PMID:
9990697
33.
34.

Radiological and clinical criteria for the management of epidural hematomas in children.

Bejjani GK, Donahue DJ, Rusin J, Broemeling LD.

Pediatr Neurosurg. 1996 Dec;25(6):302-8.

PMID:
9348150
35.

Beneficial effect of Aloe on wound healing in an excisional wound model.

Heggers JP, Kucukcelebi A, Listengarten D, Stabenau J, Ko F, Broemeling LD, Robson MC, Winters WD.

J Altern Complement Med. 1996 Summer;2(2):271-7.

PMID:
9395659
36.

A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption.

Lu LJ, Broemeling LD, Marshall MV, Ramanujam VM.

Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):497-503.

37.

Long-term reduction in bone mass after severe burn injury in children.

Klein GL, Herndon DN, Langman CB, Rutan TC, Young WE, Pembleton G, Nusynowitz M, Barnett JL, Broemeling LD, Sailer DE, et al.

J Pediatr. 1995 Feb;126(2):252-6.

PMID:
7844672
38.

In vivo characterization of interleukin-4 as a potential wound healing agent.

Kucukcelebi A, Harries RH, Hennessey PJ, Phillips LG, Broemeling LD, Listengarten D, Ko F, Narula S, Robson MC.

Wound Repair Regen. 1995 Jan-Mar;3(1):49-58.

PMID:
17168862
39.

Determinants of free-living energy expenditure in normal weight and obese women measured by doubly labeled water.

Hibbert JM, Broemeling LD, Isenberg JN, Wolfe RR.

Obes Res. 1994 Jan;2(1):44-53. Erratum in: Obes Res. 1994 May;2(3):303.

40.

Measuring intrasubject variability: use of the jacknife in doubly labeled water experiments.

Broemeling LD, Wolfe RR.

J Appl Physiol (1985). 1993 Oct;75(4):1507-12.

PMID:
8282596
41.

Application of basic fibroblast growth factor may reverse diabetic wound healing impairment.

Phillips LG, Abdullah KM, Geldner PD, Dobbins S, Ko F, Linares HA, Broemeling LD, Robson MC.

Ann Plast Surg. 1993 Oct;31(4):331-4.

PMID:
8239433
42.

Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media.

Sung BS, Chonmaitree T, Broemeling LD, Owen MJ, Patel JA, Hedgpeth DC, Howie VM.

Clin Infect Dis. 1993 Jul;17(1):38-42.

PMID:
8394749
43.

Caloric requirements of patients with burns under one year of age.

Hildreth MA, Herndon DN, Desai MH, Broemeling LD.

J Burn Care Rehabil. 1993 Jan-Feb;14(1):108-12.

PMID:
8454656
44.

The effect of denervation on soft-tissue infection pathophysiology.

Alison WE Jr, Phillips LG, Linares HA, Hui PS, Hayward PG, Broemeling LD, Heggers JP, Robson MC.

Plast Reconstr Surg. 1992 Dec;90(6):1031-5.

PMID:
1448497
45.

The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores.

Robson MC, Phillips LG, Lawrence WT, Bishop JB, Youngerman JS, Hayward PG, Broemeling LD, Heggers JP.

Ann Surg. 1992 Oct;216(4):401-6; discussion 406-8.

46.

Efficacy of leupeptin, superoxide dismutase, and verapamil in modulating delayed reperfusion damage after burn injury.

Xia ZF, Barrow RE, He F, Broemeling LD, Herndon DN.

J Burn Care Rehabil. 1992 Sep-Oct;13(5):530-7.

PMID:
1452586
47.

Reperfusion injury in burned rats after delayed fluid resuscitation.

Xia ZF, He F, Barrow RE, Broemeling LD, Herndon DN.

J Burn Care Rehabil. 1991 Sep-Oct;12(5):430-6.

PMID:
1752877
48.

Testing for a change point in registry data with an example of hypospadias.

Broemeling LD, Palmer J.

Stat Med. 1991 Jul;10(7):1159-60. No abstract available.

PMID:
1876803
49.

Current treatment reduces calories required to maintain weight in pediatric patients with burns.

Hildreth MA, Herndon DN, Desai MH, Broemeling LD.

J Burn Care Rehabil. 1990 Sep-Oct;11(5):405-9.

PMID:
2123202
50.

Confidence intervals for measures of heritability.

Broemeling LD.

Biometrics. 1969 Jun;25(2):424-7. No abstract available.

PMID:
5794106

Supplemental Content

Loading ...
Support Center